CKDu and Ochratoxin-A: risk assessment studies in a microphysiological system
CKDu 和赭曲霉毒素-A:微生理系统中的风险评估研究
基本信息
- 批准号:10197129
- 负责人:
- 金额:$ 18.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-17 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalActive Biological TransportAcute Renal Failure with Renal Papillary NecrosisAnimalsApicalAristolochic AcidsBiological MarkersBiological ModelsBiomimeticsCarcinogensCarrier ProteinsCell LineCellsCerealsChemicalsChronicChronic Kidney FailureCoffeeCoupledDevelopmentDoseDrug Metabolic DetoxicationEngineeringEnzymesEtiologyExhibitsExposure toFoodFruitGrainHazard IdentificationHeat Stress DisordersHepaticHepatocyteHumanIndividualIngestionInjuryInjury to KidneyKidneyKidney DiseasesKineticsLinkLiverMeasuresMediatingMembraneMetabolismMicrofluidicsModelingMolecular ProfilingMycotoxinsNo-Observed-Adverse-Effect LevelOccupationalOutcomePathway interactionsPharmaceutical PreparationsPhasePlayPoliciesPopulationPreventionPropertyProximal Kidney TubulesPublic HealthRisk AssessmentRisk FactorsRoleSeriesSourceSupport SystemTeaTransport ProcessWagesWineagricultural communitybasebeanbiophysical propertiescarcinogenicitycell immortalizationcostdietaryexposure routegene environment interactiongenetic risk factorglobal healthhigh risk populationhot climatehuman tissueinnovationinsightkidney cellliver metabolismlow income countrymicrophysiology systemnephrotoxicityochratoxin Aresponsesocioeconomicstransport inhibitoruptake
项目摘要
Project Summary/Abstract
CKDu (CKD of unknown etiology) occurs primarily in the developing world, and is associated with living and
working in agricultural communities in hot climates. The cost of treating CKDu is unattainable in low-income
countries, where 30 days of essential medications can cost up to 18 days wages. One proposed risk factor of
CKDu is chronic exposure to Ochratoxin A (OTA), a common mycotoxin found in cereal grains, beans, dried
fruits, wine, coffee, and tea. OTA is a demonstrated renal carcinogen in several animal species, however
hazard identification in humans has been elusive due to the lack of adequate models that include hepatic
bioactivation as a source of the ultimate toxic moiety.
We have recently developed a coupled liver>kidney microphysiologic system (MPS) that was used to identify
the specific hepatic enzymes, renal transporters, and intermediate chemical metabolites associated with
aristolochic acid mediated CKDu. Cultured under constant flow, primary liver and kidney cells demonstrated
localized phase-I/II enzymes and transporters, a significant advance over immortalized cell lines that rapidly
lose enzyme expression and transporter polarization. In addition, primary kidney proximal tubule cells exhibited
robust and biomimetic secretion of biomarkers of kidney injury.
For this proposal, we have developed an innovative integrated liver>kidney MPS that incorporates both a
coupled and uncoupled kidney MPS on a single chip. We propose to define the dose-response relationships of
ochratoxin A and heat stress-induced nephropathy, identify the transport proteins involved in renal ochratoxin
A uptake and efflux, and determine the role of first pass metabolism in ochratoxin A-induced nephropathy. A
better understanding of the mechanisms of OTA-induced kidney injury will support changes in risk assessment,
regulatory agency policies on allowable exposure levels, and determination of genetic risk factors in high-risk
populations.
项目概要/摘要
CKDu(病因不明的 CKD)主要发生在发展中国家,与生活和生活有关。
在气候炎热的农业社区工作。低收入人群无法承担治疗 CKDu 的费用
在一些国家,30 天的基本药物费用可能高达 18 天的工资。一项建议的风险因素
CKDu 是指长期接触赭曲霉毒素 A (OTA),这是一种常见的霉菌毒素,存在于谷物、豆类、干货中。
水果、酒、咖啡和茶。然而,OTA 已被证明是多种动物的肾致癌物
由于缺乏包括肝脏在内的适当模型,人类的危害识别一直难以捉摸。
生物活化作为最终毒性部分的来源。
我们最近开发了一个耦合的肝脏>肾脏微生理系统(MPS),用于识别
与相关的特定肝酶、肾转运蛋白和中间化学代谢物
马兜铃酸介导的 CKDu。在恒流培养下,原代肝细胞和肾细胞被证明
局部 I/II 期酶和转运蛋白,相对于永生化细胞系来说是一个重大进步,
失去酶表达和转运蛋白极化。此外,原代肾近曲小管细胞表现出
肾损伤生物标志物的稳健和仿生分泌。
对于这个提案,我们开发了一种创新的集成肝>肾 MPS,它结合了
在单个芯片上耦合和非耦合肾脏 MPS。我们建议定义剂量反应关系
赭曲霉毒素 A 和热应激诱发的肾病,鉴定参与肾赭曲霉毒素的转运蛋白
A 的摄取和流出,并确定首过代谢在赭曲霉毒素 A 诱导的肾病中的作用。一个
更好地了解 OTA 引起的肾损伤的机制将支持风险评估的变化,
监管机构关于允许暴露水平的政策以及高风险遗传风险因素的确定
人口。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD J KELLY其他文献
EDWARD J KELLY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD J KELLY', 18)}}的其他基金
CKDu and Ochratoxin-A: risk assessment studies in a microphysiological system
CKDu 和赭曲霉毒素-A:微生理系统中的风险评估研究
- 批准号:
10056622 - 财政年份:2020
- 资助金额:
$ 18.27万 - 项目类别:














{{item.name}}会员




